Bradford Crutchfield - 12 Jul 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
12 Jul 2021
Net transactions value
-$3,151,276
Form type
4
Filing time
14 Jul 2021, 16:42:29 UTC
Previous filing
16 Jun 2021
Next filing
16 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $19,720 +17,000 +39% $1.16 60,606 12 Jul 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $1,065,097 -5,755 -9.5% $185.07 54,851 12 Jul 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $817,811 -4,400 -8% $185.87 50,451 12 Jul 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $736,674 -3,933 -7.8% $187.31 46,518 12 Jul 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale $284,733 -1,512 -3.3% $188.32 45,006 12 Jul 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale $94,682 -500 -1.1% $189.36 44,506 12 Jul 2021 Direct F1, F7
transaction TXG Class A Common Stock Sale $114,518 -600 -1.3% $190.86 43,906 12 Jul 2021 Direct F1, F8
transaction TXG Class A Common Stock Sale $57,481 -300 -0.68% $191.60 43,606 12 Jul 2021 Direct F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -17,000 -3.2% $0.000000 511,000 12 Jul 2021 Class A Common Stock 17,000 $1.16 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 Includes an aggregate of 344 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan.
F3 This transaction was executed in multiple trades at prices ranging from $184.47 to $185.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $185.47 to $186.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $186.90 to $187.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $188.015 to $188.945. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $189.07 to $189.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $190.41 to $191.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $191.445 to $191.91. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 This option, originally for 800,000 shares, of which 289,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.